{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T05:34:11Z","timestamp":1648532051414},"reference-count":28,"publisher":"Japanese Association of Virology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2009]]},"DOI":"10.2222\/jsv.59.277","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T06:07:15Z","timestamp":1278310035000},"page":"277-286","source":"Crossref","is-referenced-by-count":1,"title":["Global Polio Eradication Program: Fundamental Lessons for the Control of Infectious Diseases"],"prefix":"10.2222","volume":"59","author":[{"given":"Tatsuo","family":"MIYAMURA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","unstructured":"1)Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID: Smallpox and its eradication, Geneva. WHO, 1988."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2)Salk JE, Krech U, Youngner JS, Bennett BL, Lewis LJ, Bazeley PL: Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. Am. J. Public Health 44: 563-570, 1954.","DOI":"10.2105\/AJPH.44.5.563"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3)Sabin, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH, et al.: Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. JAMA 173:1521-1526, 1960.","DOI":"10.1001\/jama.1960.03020320001001"},{"key":"4","unstructured":"4)Landsteiner K, Popper E: Übertragung der Poliomyelitis acuta auf Affen. Z Immunitätsforsch 2: 377-390, 1909."},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1126\/science.2994218"},{"key":"6","unstructured":"6)Burnet FM, Macnamara J: Immunological differences between strains of poliomyelitic virus. Br. J. Exp. Pathol. 12: 57-61, 1931."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7)Enders JF, Weller TH, Robbins FC: Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109: 85-87, 1949.","DOI":"10.1126\/science.109.2822.85"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1038\/291547a0"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1126\/science.6272391"},{"issue":"8(Biol Sci)","key":"10","first-page":"4887","volume":"78","year":"1981","ISSN":"http:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90690-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12)Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N, Takeuchi K, Takegami T, Nomoto A: The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 10: 3217-3224, 1990.","DOI":"10.1002\/j.1460-2075.1990.tb07520.x"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.3.951"},{"key":"14","unstructured":"14)Melnick JL: Advantages and disadvantages of the killed and live poliomyelitis vaccines. Bull. WHO 56: 21-38, 1978."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Nathanson N, Langmuir AD: The Cutter Incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States in the spring of 1955. I. Background. Am. J. Hyg. 78:16-28, 1963.","DOI":"10.1093\/oxfordjournals.aje.a120327"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16)Koprowski H, Jervis GA, Norton TW: Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am. J. Hyg. 55: 108-126, 1952.","DOI":"10.1093\/oxfordjournals.aje.a119499"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/0092-1157(73)90048-6"},{"issue":"2","key":"18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7883\/yoken1952.34.109","volume":"34","year":"1981","ISSN":"http:\/\/id.crossref.org\/issn\/0021-5112","issn-type":"print"},{"key":"19","unstructured":"19)World Health Assembly 1988: Polio eradication by the year of 2000. Rep.Resolution 41.28. Geneva. WHO."},{"key":"20","doi-asserted-by":"publisher","DOI":"10.2222\/jsv.59.43"},{"key":"21","unstructured":"21)WHO: Transmission of wild poliovirus type 2: apparent global interruption. Wkly. Epidemiol. Rec. 76: 95-97, 2001."},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.58.030603.123625"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.24.13512-13521.2004"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.20.12650-12657.2005"},{"issue":"9","key":"26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1348-0421.1981.tb00095.x","volume":"25","year":"1981","ISSN":"http:\/\/id.crossref.org\/issn\/0385-5600","issn-type":"print"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.0003"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.7.3001-3010.2000"}],"container-title":["Uirusu"],"original-title":[],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:40:52Z","timestamp":1621532452000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jsv\/59\/2\/59_2_277\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.59.277","relation":{},"ISSN":["0042-6857"],"issn-type":[{"value":"0042-6857","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}